SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-019700
Filing Date
2019-12-26
Accepted
2019-12-26 09:00:30
Documents
2
Period of Report
2019-12-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 48792
2 ex3-1.htm EX-3.1 45682
  Complete submission text file 0001493152-19-019700.txt   95942
Mailing Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334
Business Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334 972-72-2608004
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54856 | Film No.: 191308466
SIC: 3841 Surgical & Medical Instruments & Apparatus